De Souza, C A <br/><br/>
Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study.  [electronic resource] 

 -  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas  Jul 2000 
 - 791-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0100-879X 
<br/><br/><label>Standard No.: </label>10.1590/s0100-879x2000000700009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Amifostine--adverse effects<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Cytoprotection--drug effects<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Radiation-Protective Agents--adverse effects<br/>Statistics, Nonparametric<br/>Treatment Outcome